```html

Quartan Fever (Malaria) – A Complete Patient Guide

Overview

Quartan fever is a form of malaria caused primarily by the parasite Plasmodium malariae. Unlike the more common P. vivax (tertian) and P. falciparum (often severe) infections, quartan malaria produces a fever spike approximately every 72 hours (four‑day cycle), hence the name “quartan.”

Although malaria is a global disease, quartan malaria accounts for only 1–2 % of all malaria cases worldwide. It is most frequently reported in parts of sub‑Saharan Africa, the Amazon basin, Papua New Guinea, and some islands of the Western Pacific. According to the World Health Organization (WHO), there were an estimated 232 million malaria cases in 2022, with roughly 0.5–1 million attributable to P. malariae (WHO, 2023).

Anyone traveling to or living in endemic regions can be infected, but risk is higher for:

• Children and pregnant women (because malaria can impair fetal growth).
• People with weakened immune systems (e.g., HIV, organ‑transplant recipients).
• Workers who spend extended periods outdoors at night (e.g., agricultural laborers, miners).

Symptoms

Symptoms of quartan fever typically appear 18‑40 days after the bite of an infected Anopheles mosquito, but can emerge months later because P. malariae can remain dormant in the bloodstream.

Classic fever pattern

• Quartan fever spikes – High fever (38–40 °C / 100.4–104 °F) every 72 hours, often with chills and rigors preceding the rise.

Accompanying systemic signs

• Headache – Dull or throbbing, may be worse with fever.
• Generalized body aches – Myalgia, especially in the back and joints.
• Fatigue and weakness – Can persist for weeks after parasite clearance.
• Nausea / vomiting – Often coincides with the fever spike.
• Diarrhea – Less common but reported.
• Sweating – Profuse sweating as fever resolves.
• Jaundice – Yellowing of skin/eyes if the liver is involved.
• Anemia – Due to destruction of red blood cells; may cause pallor.
• Splenomegaly – Enlarged spleen causing left‑upper‑quadrant discomfort.

Because the fever cycle is less frequent than in tertian malaria, many patients initially mistake quartan fever for other infections (e.g., viral illnesses or bacterial sepsis), which can delay diagnosis.

Causes and Risk Factors

What causes quartan fever?

Quartan fever results from the blood stage of Plasmodium malariae, transmitted by the bite of an infected female Anopheles mosquito. The parasite invades red blood cells (RBCs), multiplies, and causes the cyclic rupture of RBCs, leading to the characteristic fever spikes.

Key risk factors

• Geographic exposure – Living in or traveling to endemic regions.
• Lack of vector control – Absence of insecticide‑treated nets (ITNs) or indoor residual spraying.
• Non‑adherence to prophylaxis – Skipping antimalarial preventive meds.
• Occupational exposure – Night‑time outdoor work.
• Immunocompromised state – HIV/AIDS, malnutrition, or immunosuppressive therapy.
• Pregnancy – Hormonal changes increase mosquito attraction and reduce immunity.

Diagnosis

Prompt diagnosis is essential because untreated malaria can lead to severe organ damage. The following tests are routinely used:

1. Microscopic blood smear (Gold standard)

• Thick smear – Concentrates parasites for detection (high sensitivity).
• Thin smear – Allows species identification and parasite density estimation.

2. Rapid Diagnostic Tests (RDTs)

Immunochromatographic tests that detect parasite antigens (e.g., HRP‑2, pLDH). While RDTs are quick (<15 min), they are less reliable for P. malariae because many kits target P. falciparum antigens. A negative RDT in a febrile traveler should still prompt a microscopy exam.

3. Polymerase Chain Reaction (PCR)

Highly specific molecular test that can differentiate Plasmodium species, useful in low‑parasitemia cases or for confirming mixed infections.

4. Additional laboratory tests

• Complete blood count (CBC) – Often shows anemia, thrombocytopenia.
• Liver function tests – May reveal elevated bilirubin, transaminases.
• Renal panel – Chronic P. malariae can cause nephrotic syndrome.

Treatment Options

Treatment aims to eradicate parasites, relieve symptoms, and prevent recurrence. Because P. malariae is generally sensitive to chloroquine, the recommended regimens differ from those for P. falciparum.

First‑line pharmacologic therapy

• Chloroquine phosphate – 25 mg/kg total dose given over 3 days (10 mg/kg on day 1, 10 mg/kg on day 2, 5 mg/kg on day 3). Effective in >95 % of cases where resistance is absent (CDC, 2024).
• If chloroquine resistance is suspected or confirmed, alternatives include:
  • Artemisinin‑based combination therapy (ACT) – e.g., artesunate + amodiaquine for 3 days.
  • Mefloquine – 1250 mg single dose (or divided) for uncomplicated cases.

Adjunctive measures

• Fever control – Paracetamol (acetaminophen) 500‑1000 mg every 6 h as needed (avoid NSAIDs if renal impairment).
• Hydration – Oral rehydration solutions or IV fluids for severe dehydration.
• Blood transfusion – In cases of severe anemia (Hb < 7 g/dL).

Special considerations

• Pregnancy – Chloroquine is safe in all trimesters; ACTs (artesunate‑based) are recommended for P. falciparum but can be used for P. malariae when chloroquine resistance is present.
• Children – Dosing is weight‑based; monitor for hypoglycemia with quinine‑based regimens.
• G6PD deficiency – Avoid primaquine (not typically required for P. malariae but used for hypnozoite‑forming species).

Living with Quartan Fever (Malaria)

Even after successful treatment, some patients may experience lingering fatigue or intermittent low‑grade fevers for weeks. Here are practical tips for daily management:

• Complete the full medication course – Skipping doses can lead to recrudescence.
• Rest and gradual activity – Start with light tasks; avoid strenuous exercise until energy returns.
• Nutrition – High‑iron foods (lean meat, beans, leafy greens) to support recovery from anemia; vitamin C to improve iron absorption.
• Hydration – Aim for 2–3 L of fluid daily; electrolyte solutions if there is persistent vomiting or diarrhea.
• Monitor fever – Keep a log of temperature spikes; report any resurgence to a clinician.
• Follow‑up labs – Repeat CBC and parasitemia test 7‑10 days after treatment to confirm clearance.
• Protect your spleen – Avoid contact sports for at least 3 months if splenomegaly was noted.

Prevention

Prevention focuses on reducing mosquito exposure and, when appropriate, taking chemoprophylaxis.

Vector control

• Sleep under insecticide‑treated bed nets (ITNs) every night.
• Use indoor residual spraying (IRS) in homes when available.
• Wear long‑sleeved shirts and pants, especially from dusk to dawn.
• Apply EPA‑approved repellents containing DEET (20‑30 %), picaridin, or oil of lemon eucalyptus.
• Eliminate standing water around dwellings to reduce breeding sites.

Chemoprophylaxis (for travelers)

• Atovaquone‑proguanil (Malarone) – Start 1‑2 days before travel, continue daily throughout stay, and 7 days after leaving.
• Doxycycline – Begin 1–2 days before travel, take daily, and continue for 4 weeks after departure.
• Mefloquine – Start 2–3 weeks before travel (due to neuropsychiatric side effects), continue weekly during exposure and for 4 weeks after.

Select a regimen after discussing medical history with a health‑care provider.

Vaccination

As of 2024, the RTS,S/AS01 (Mosquirix) vaccine is approved for P. falciparum in children; research on a pan‑Plasmodium vaccine is ongoing, but no vaccine specifically prevents P. malariae yet.

Complications

When left untreated or inadequately treated, quartan malaria can lead to serious health problems:

• Chronic anemia – Persistent RBC destruction.
• Renal disease – P. malariae is uniquely associated with nephrotic syndrome and chronic glomerulonephritis.
• Splenomegaly – Can cause hypersplenism and increased risk of rupture.
• Respiratory distress – From severe anemia or metabolic acidosis.
• Cerebral involvement – Rare but reported in high‑parasitemia cases.
• Pregnancy complications – Low birth weight, preterm delivery, and maternal anemia.

When to Seek Emergency Care

---

For the most up‑to‑date information, consult reputable sources such as the Mayo Clinic, the Centers for Disease Control and Prevention, the National Institutes of Health, and the World Health Organization.

```